Rob Fijnheer

3.3k total citations · 1 hit paper
32 papers, 2.6k citations indexed

About

Rob Fijnheer is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Rob Fijnheer has authored 32 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 14 papers in Immunology and 8 papers in Genetics. Recurrent topics in Rob Fijnheer's work include Platelet Disorders and Treatments (15 papers), Complement system in diseases (10 papers) and Hemoglobinopathies and Related Disorders (5 papers). Rob Fijnheer is often cited by papers focused on Platelet Disorders and Treatments (15 papers), Complement system in diseases (10 papers) and Hemoglobinopathies and Related Disorders (5 papers). Rob Fijnheer collaborates with scholars based in Netherlands, Indonesia and Germany. Rob Fijnheer's co-authors include Jan J. Sixma, Hans J. Geuze, Harry F.G. Heijnen, Quirijn de Mast, Philip G. de Groot, André van der Ven, Catharina J.M. Frijns, H K Nieuwenhuis, Jaap J. Beutler and J J Sixma and has published in prestigious journals such as Blood, PLoS ONE and Neurology.

In The Last Decade

Rob Fijnheer

32 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules

1999 1.2k citations Rob Fijnheer, Jan J. Sixma et al. Blood profile →

Peers

Countries citing papers authored by Rob Fijnheer

Since Specialization

Citations

This map shows the geographic impact of Rob Fijnheer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Fijnheer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Fijnheer more than expected).

Fields of papers citing papers by Rob Fijnheer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Fijnheer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Fijnheer. The network helps show where Rob Fijnheer may publish in the future.

Co-authorship network of co-authors of Rob Fijnheer

This figure shows the co-authorship network connecting the top 25 collaborators of Rob Fijnheer. A scholar is included among the top collaborators of Rob Fijnheer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Fijnheer. Rob Fijnheer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Truncation of ADAMTS13 by Plasmin Enhances Its Activity in Plasma 2018 ·Thrombosis and Haemostasis ·(unknown), Mirjam M. Mebius, Steven de Maat, Aloysius G. M. Tielens, Philip de Groot, Rolf T. Urbanus, Rob Fijnheer, Bouke P. C. Hazenberg, Jaap J. van Hellemond, Coen Maas	7
2	Secondary thrombotic microangiopathy with severely reduced ADAMTS13 activity in a patient with Capnocytophaga canimorsus sepsis: a case report 2018 ·Transfusion ·(unknown), Rob Fijnheer, Silvie Sebastian, Quirijn de Mast	13
3	Differential effects of platelets and platelet inhibition by ticagrelor on TLR2- and TLR4-mediated inflammatory responses 2015 ·Thrombosis and Haemostasis ·André van der Ven, Niels P. Riksen, Gerard A. Rongen, Sabine Tacke, (unknown), Rob Fijnheer, Marc E. Gomes, Charles A. Dinarello, Frank L. van de Veerdonk, Muhammad Hussein Gasem, Mihai G. Netea, Leo A. B. Joosten, Philip G. de Groot, Quirijn de Mast, Rahajeng N. Tunjungputri	44
4	Is asymptomatic malaria really asymptomatic? Hematological, vascular and inflammatory effects of asymptomatic malaria parasitemia 2015 ·Journal of Infection ·Quirijn de Mast, (unknown), Din Syafruddin, Teun Bousema, Amrish Baidjoe, Philip G. de Groot, André van der Ven, Rob Fijnheer	46
5	Reduced platelet hyperreactivity and platelet-monocyte aggregation in HIV-infected individuals receiving a raltegravir-based regimen 2014 ·AIDS ·Rahajeng N. Tunjungputri, André van der Ven, (unknown), Till S. M. Mathan, Peter J. Koopmans, Mark Roest, Rob Fijnheer, Philip G. de Groot, Quirijn de Mast	31
6	Platelet Activation Determines Angiopoietin-1 and VEGF Levels in Malaria: Implications for Their Use as Biomarkers 2013 ·PLoS ONE ·(unknown), Rintis Noviyanti, Rob Fijnheer, Philip G. de Groot, Leily Trianty, (unknown), Mark Roest, Din Syafruddin, André van der Ven, Quirijn de Mast	29
7	Severe Dengue Is Associated with Consumption of von Willebrand Factor and Its Cleaving Enzyme ADAMTS-13 2012 ·PLoS neglected tropical diseases ·(unknown), André van der Ven, Philip G. de Groot, Sultana MH Faradz, (unknown), W.M.V. Dolmans, Silvie Sebastian, Rob Fijnheer, Quirijn de Mast	57
8	IL-18 Serum Concentration Is Markedly Elevated in Acute EBV Infection and Can Serve as a Marker for Disease Severity 2012 ·The Journal of Infectious Diseases ·Frank L. van de Veerdonk, Peter C. Wever, Mirjam H. A. Hermans, Rob Fijnheer, Leo A. B. Joosten, Jos W.M. van der Meer, Mihai G. Netea, Peter M. Schneeberger	43
9	Thrombocytopenia in early malaria is associated with GP1b shedding in absence of systemic platelet activation and consumptive coagulopathy 2010 ·British Journal of Haematology ·Quirijn de Mast, Philip G. de Groot, Waander L. van Heerde, Meta Roestenberg, Jeroen F. van Velzen, Bert Verbruggen, Mark Roest, Matthew B. B. McCall, (unknown), (unknown), Din Syafruddin, Rob Fijnheer, Edmée C. van Dongen-Lases, Robert W. Sauerwein, André van der Ven	44
10	Thrombocytopenia and Release of Activated von Willebrand Factor during EarlyPlasmodium falciparumMalaria 2007 ·The Journal of Infectious Diseases ·Quirijn de Mast, Evelyn Groot, Peter J. Lenting, Philip G. de Groot, Matthew B. B. McCall, Robert W. Sauerwein, Rob Fijnheer, André van der Ven	85
11	Neurologic and hematologic response to fludarabine treatment in IgM MGUS polyneuropathy 2006 ·Neurology ·J.M.F. Niermeijer, M. Eurelings, (unknown), Harrie‐Jan Hendricks Franssen, Rob Fijnheer, John H. J. Wokke, Nicolette C. Notermans	24
12	Spinal Dural Arteriovenous Fistulas Are Not Associated With Prothrombotic Factors 2004 ·Stroke ·Korné Jellema, Cees Tijssen, Rob Fijnheer, Philip G. de Groot, P. J. Koudstaal, J. van Gijn	18
13	Semicarbazide-sensitive amine oxidase in pre-eclampsia: no relation with markers of endothelial cell activation 2002 ·Clinica Chimica Acta ·J. Sikkema, Arie Franx, Rob Fijnheer, Peter G. J. Nikkels, Hein W. Bruinse, Frans Boomsma	8
14	Plasma Levels of Cellular Fibronectin in Diabetes 2001 ·Diabetes Care ·S. D. J. M. Kanters, Jan-Dirk Banga, Ale Algra, (unknown), Jaap J. Beutler, Rob Fijnheer	79
15	Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus 2001 ·Clinical & Experimental Immunology ·Catharina J.M. Frijns, R. H. W. M. Derksen, (unknown), Ale Algra, Rob Fijnheer	22
16	von Willebrand Factor Proteolysis Is Deficient in Classic, but not in Bone Marrow Transplantation–Associated, Thrombotic Thrombocytopenic Purpura 1999 ·Blood ·R. Martijn van der Plas, Marion E. Schiphorst, Eric G. Huizinga, Ronald J. Hené, Leo F. Verdonck, Jan J. Sixma, Rob Fijnheer	5
17	Progressive vascular damage in hypertension is associated with increased levels of circulating P-selectin 1998 ·Journal of Hypertension ·Marianne C. Verhaar, Jaap J. Beutler, Sandrine Gaillard, Hein A. Koomans, Rob Fijnheer, Ton J. Rabelink	122
18	Cyclosporin for thrombotic thrombocytopenic purpura after autologous bone marrow transplantation 1997 ·British Journal of Haematology ·(unknown), Douwe H. Biesma, Rob Fijnheer, Ronald J. Hené, Henk M. Lokhorst, (unknown), (unknown), (unknown)	18
19	Improvement of platelet storage conditions by using new polyolefin containers 1997 ·Transfusion ·Janny De Wildt‐Eggen, (unknown), (unknown), Rob Fijnheer, M. Bins, H. C. van Prooijen	40
20	Factor V Leiden, Antiphospholipid Antibodies and Thrombosis in Systemic Lupus Erythematosus 1996 ·Thrombosis and Haemostasis ·Rob Fijnheer, D. A. Horbach, R C J M Donders, (unknown), Erica van Oort, H K Nieuwenhuis, (unknown), Ph.G. de Groot, R. H. W. M. Derksen	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact